A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease

Abstract

T and B cell responses to ECGF occur in a subset of patients with Lyme disease, particularly in those with antibiotic-refractory arthritis, providing the first direct evidence of autoimmune T and B cell responses in this illness.